Pancreatic Cancer Research

ResearcherThe University of OsakaActive in the last 2 years

Ryosuke Maki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9486-0612; OpenAlex author ID A5008129352. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2025: 2 papers

Papers 2

  1. Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations. Co-author DOI 10.1245/s10434-025-17482-8↗
  2. ASO Author Reflections: Efficacy of SOAT1 Inhibitors against Pancreatic Cancer with TP53 Mutations. Co-author DOI 10.1245/s10434-025-17667-1↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tadafumi Asaoka · 2 shared papers, 2025 · strength 0.44
  2. Yuichiro Doki · 2 shared papers, 2025 · strength 0.44
  3. Yoshifumi Iwagami · 2 shared papers, 2025 · strength 0.44
  4. Yoshito Tomimaru · 2 shared papers, 2025 · strength 0.44
  5. Daisaku Yamada · 2 shared papers, 2025 · strength 0.44
  6. Hidenori Takahashi · 2 shared papers, 2025 · strength 0.44
  7. Kazuki Sasaki · 2 shared papers, 2025 · strength 0.44
  8. Hidetoshi Eguchi · 1 shared paper, 2025 · strength 0.22
  9. Hidetoshi Eguchi · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.